The deadly landscape of pro-apoptotic BCL-2 proteins in the outer mitochondrial membrane

FEBS Journal

Volumn , Issue , 2016, Pages 2676-2689

  Luna Vargas, Mark P A ^a   Chipuk, Jerry E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; BAK; BAX; BCL 2 family; lipids; membrane; mitochondria; mitochondrial landscape; MOMP; Structure

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BCL2 RELATED PROTEIN A1; BH3 PROTEIN; BIM PROTEIN; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 9; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN MCL 1; PROTEIN P53;

ALPHA HELIX; APOPTOSIS; BIOPHYSICS; CELL SURVIVAL; DIMERIZATION; ENDOPLASMIC RETICULUM STRESS; HUMAN; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; RAT; REVIEW; STRUCTURE ANALYSIS;

EID: 84978967307     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13624     Document Type: Review

References (120)

1. Kerr JF, Wyllie AH & Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239–257.
2. Hotchkiss RS, Strasser A, McDunn JE & Swanson PE (2009) Cell death in disease: mechanisms and emerging therapeutic concepts. N Engl J Med 361, 1670–1683.
3. Riedl SJ & Galvesen GS (2007) The apoptosome: signaling platform of cell death. Nat Rev Mol Cell Biol 8, 405–413.
4. Tait SW & Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11, 621–632.
5. Yuan S & Akey CW (2013) Apoptosome structure, assembly, and procaspase activation. Structure 21, 501–515.
6. Czabotar PE, Lessene G, Strasser A & Adams JM (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 15, 49–63.
7. Hu Q, Wu D, Chen W, Yan Z, Yan C, He T, Liang Q & Shi Y (2014) Molecular determinants of caspase-9 activation by the APAF-1 apoptosome. Proc Natl Acad Sci USA 111, 16254–16261.
8. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ & Green DR (2010) The BCL-2 family reunion. Mol Cell 37, 299–310.
9. Renault TT & Chipuk JE (2014) Death upon a kiss: mitochondrial outer membrane composition and organelle communication govern sensitivity to BAK/BAX-dependent apoptosis. Chem Biol 21, 114–123.
10. Rech de Laval V, Deleage G, Aouacheria A & Combet C (2014) BCL2DB: database of BCL-2 family members and BH3-only proteins. Database (Oxford) 2014, bau013.
11. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong SL et al. (1996) X-ray and NMR structure of human BCL-XL, an inhibitor of programmed cell death. Nature 381, 335–341.
12. Yin XM, Oltvai ZN & Korsmeyer SJ (1994) BH1 and BH2 domains of BCL-2 are required for inhibition of apoptosis and heterodimerization with BAX. Nature 369, 321–323.
13. Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ et al. (1997) Structure of BCL-CL–BAK peptide complex: recognition between regulators of apoptosis. Science 275, 983–986.
14. Diaz JL, Oltersdorf T, Horne W, McConnell M, Wilson G, Weeks S, Garcia T & Fritz LC (1997) A common binding site mediates heterodimerization and homodimerization of BCL-2 family members. J Biol Chem 17, 11350–11355.
15. Wang K, Gross A, Waksman G & Korsmeyer SJ (1998) Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing. Mol Cell Biol 18, 6083–6089.
16. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM & Huang DC (2005) Differential targeting of prosurvival BCL-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17, 393–403.
17. Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR & Newmeyer DD (2005) BH3 domains of BH3-only proteins differentially regulate BAX-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17, 525–535.
18. Smits C, Czabotar PE, Hinds MG & Day CL (2008) Structural plasticity underpins promiscuous binding of the prosurvival protein A1. Structure 16, 818–829.
19. Lee EF, Dewson G, Evangelista M, Pettikiriachchi A, Gold GJ, Zhu H, Colman PM & Fairlie WD (2014) The functional difference between pro-survival and pro-apoptotic B cell lymphoma 2 (BCL-2) proteins depend on structural differences in their BCL-2 homology 3 (BH3) domains. J Biol Chem 289, 36001–36017.
20. Doerflinger M, Glab JA & Puthalakath H (2015) BH3-only proteins: a 20-year stock-take. FEBS J 282, 1006–1016.
21. Ren D, Tu HC, Kim H, Wang GX, Bean GR, Takeuchi O, Jeffers JR, Zambetti GP, Hsieh JJ & Cheng EH (2010) BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science 330, 1390–1393.
22. Chen HC, Kanai M, Inoue-Yamauchi A, Tu HC, Huang Y, Ren D, Kim H, Takeda S, Reyna DE, Chan PM et al. (2015) An interconnected hierarchical model of cell death regulation by the BCL-2 family. Nat Cell Biol 17, 1270–1281.
23. Chipuk JE, Fisher JC, Dillon CP, Kriwacki RW, Kuwana T & Green DR (2008) Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc Natl Acad Sci USA 105, 20327–20332.
24. McDonnel JM, Fushman D, Milliman CL, Korsmeyer SJ & Cowburn D (1999) Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96, 625–634.
25. Chou JJ, Li H, Salvesen GS, Yuan J & Wagner G (1999) Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96, 615–624.
26. Li H, Zhu H, Xu CJ & Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491–501.
27. Luo X, Budihardjo I, Zou H, Slaughter C & Wang X (1998) BID, a BCL-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481–490.
28. Wang Y & Tjandra N (2013) Structural insights of tBid, the caspase-8-activated Bid, and its BH3 domain. J Biol Chem 288, 35840–35851.
29. Moldoveanu T, Liu Q, Tocilj A, Watson M, Shore G & Gehring K (2006) The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol Cell 24, 677–688.
30. Suzuki M, Youle RJ & Tjandra N (2000) Structure of BAX: coregulation of dimer formation and intracellular localization. Cell 103, 645–654.
31. Wolter KG, Hsu YT, Smith CL, Nechushtan A & Xi XG (1997) Movement of BAX from the cytosol to mitochondria during apoptosis. J Cell Biol 139, 1281–1292.
32. Brock SE, Li C & Wattenberg BW (2010) The BAX carboxy-terminal hydrophobic helix does not determine organelle-specific targeting but is essential for maintaining BAX in an inactive state and for stable mitochondrial membrane insertion. Apoptosis 15, 14–27.
33. Setoguchi K, Otera H & Mihara K (2006) Cytosolic factor- and TOM-independent import of C-tail-anchored mitochondrial outer membrane proteins. EMBO J 25, 5635–5647.
34. Leshchiner ES, Braun CR, Bird GH & Walensky LD (2013) Direct activation of full-length proapoptotic BAK. Proc Natl Acad Sci USA 110, 986–995.
35. Carpio MA, Michaud M, Zhou W, Fisher JK, Walensky LD & Katz SG (2015) BCL-2 family member BOK promotes apoptosis in response to endoplasmic reticulum stress. Proc Natl Acad Sci USA 112, 7201–7206.
36. Youle RJ & Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9, 47–59.
37. Westphal D, Dewson G, Czabotar PE & Kluck RM (2011) Molecular biology of BAX and BAK activation and action. Biochim Biophys Acta 1813, 521–531.
38. Lovell JF, Billen LP, Bindner S, Shama-Din A, Fradin C, Leber B & Andrews DW (2008) Membrane binding by tBID initiates an ordered series of events culminating in membrane permeabilization by BAX. Cell 135, 1074–1084.
39. Gavathiotis E, Reyna DE, Davis ML, Bird GH & Walensky LD (2010) BH3-triggered structural reorganization drives the activation of proapoptotic BAX. Mol Cell 40, 481–492.
40. Czabotar PE, Westphal D, Dewson G, Ma S, Hockings C, Fairlie WD, Lee EF, Yao S, Robin AY, Smith BJ et al. (2013) BAX crystal structures reveal how BH3 domains activate BAX and nucleate its oligomerization to induce apoptosis. Cell 152, 519–531.
41. Gavathiotis E, Suzuki M, Davis ML, Pitter K, Bird GH, Katz SG, Tu HC, Kim H, Cheng EH, Tjandra N et al. (2008) BAX activation is initiated at a novel interaction site. Nature 255, 1076–1081.
42. Walensky LD, Pitter K, Morash J, Oh KJ, Barbuto S, Fisher J, Smith E, Verdine GL & Korsmeyer SJ (2006) A stapled BID BH3 helix directly binds and activates BAX. Mol Cell 24, 199–210.
43. Moldoveanu T, Grace CR, Llambi F, Nourse A, Fitzgerald P, Gehring K, Kriwacki RW & Green DR (2013) BID-induced structural changes in BAK promotes apoptosis. Nat Struct Mol Biol 20, 589–597.
44. Brouwer JM, Westphal D, Dewson G, Robin AY, Uren RT, Bartolo R, Thompson GV, Colman PM, Kluck RM & Czabotar PE (2014) BAK core and latch domains separate during activation, and freed core domains from symmetric homodimers. Mol Cell 55, 938–946.
45. Edlich F, Banerjee S, Suzuki M, Cleland MM, Arnoult D, Wang C, Neutzner A, Tjandra N & Youle RJ (2011) BCL-XL retrotranslocates BAX from the mitochondria into the cytosol. Cell 145, 104–116.
46. Schellenberg B, Wang P, Keeble JA, Rodriguez-Enriquez R, Walker S, Owens TW, Foster F, Tanianis-Hughes J, Brennan K, Streuli CH et al. (2013) BAX exists in a dynamic equilibrium between the cytosol and mitochondria to control apoptotic priming. Mol Cell 49, 959–971.
47. Dewson G, Ma S, Frederick P, Hockings C, Tan I, Kratina T & Kluck RM (2012) BAX dimerizes via a symmetric BH3:groove interface during apoptosis. Cell Death Differ 19, 661–670.
48. Dewson G, Kratina T, Czabotar P, Day CL, Adams JM & Kluck RM (2009) Bak activation for apoptosis involves oligomerization of dimers via their α6 helices. Mol Cell 36, 696–703.
49. Oh KJ, Singh P, Lee K, Foss K, Lee S, Park M, Lee S, Aluvila S, Park M, Singh P et al. (2010) Conformational changes in BAK, a pore-forming proapoptotic BCL-2 family member, upon membrane insertion and direct evidence for the existence of BH3–BH3 contact surface in BAK homo-oligomers. J Biol Chem 285, 28924–28937.
50. Iyer S, Bell F, Westphal D, Anwari K, Gulbis J, Smith BJ, Dewson G & Kluck RM (2015) BAK apoptotic pores involve a flexible C-terminal region and juxtaposition of the C-terminal transmembrane domains. Cell Death Differ 22, 1665–1675.
51. Westphal D, Dewson G, Menard M, Frederick P, Iyer S, Bartolo R, Gibson L, Czabotar PE, Smith BJ, Adams JM et al. (2014) Apoptotic pore formation is associated with in-plane insertion of BAK or BAX central helices into the mitochondrial outer membrane. Proc Natl Acad Sci USA 111, 4076–4085.
52. Bleicken S, Jeschke G, Stegmueller C, Salvador-Gallego R, Garcia-Saez AJ & Bordignon E (2014) Structural model of active BAX at the membrane. Mol Cell 56, 496–505.
53. Sung TC, Li CY, Lai YC, Hung CL, Shih O, Yeh YQ, Jeng US & Chiang YW (2015) Solution structure of apoptotic BAX oligomer: oligomerization likely precedes membrane insertion. Structure 23, 1878–1888.
54. Llambi F, Moldoveanu T, Tait SW, Bouchier-Hayes L, Temirov J, McCormick LL, Dillon CP & Green DR (2011) A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Mol Cell 44, 517–531.
55. Cartron PF, Oliver L, Mayat E, Meflah K & Vallette FM (2004) Impact of pH on Bax α conformation, oligomerization and mitochondrial integration. FEBS Lett 587, 41–46.
56. 2-induced apoptosis. J Biol Chem 283, 15359–15369.
57. Pagliari LJ, Kuwana T, Bonzon C, Newmeyer DD, Tu S, Beere HM & Green DR (2005) The multidomainpropapoptotic molecules Bax and Bak are directly activated by heat. Proc Natl Acad Sci USA 102, 17975–17980.
58. Elkholi R & Chipuk JE (2014) How do I kill thee? Let me count the ways: p53 regulates PARP-1 dependent necrosis. BioEssays 36, 46–51.
59. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P & Moll UM (2003) p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11, 577–590.
60. Leu JI, Dumont P, Hafey M, Murphy ME & George DL (2004) Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex. Nat Cell Biol 6, 443–450.
61. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M & Green DR (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010–1014.
62. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD & Green DR (2005) PUMA couples the nuclear and cytoplasmic proapototic function of p53. Science 309, 1732–1735.
63. Follis AV, Chipuk JE, Fisher JC, Yun ML, Grace CR, Nourse A, Baran K, Ou L, Min L, White SW et al. (2013) PUMA binding induces partial unfolding within BCL-XL to disrupt p53 binding and promote apoptosis. Nat Chem Biol 9, 163–168.
64. Follis AV, Llambi F, Merritt P, Chipuk JE, Green DR & Kriwacki RW (2015) Pin1-induced proline isomerization in cytosolic p53 mediates BAX activation and apoptosis. Mol Cell 59, 1–8.
65. Autret A & Martin SJ (2009) Emerging role for members of the BCL-2 family in mitochondrial morphogenesis. Mol Cell 36, 355–363.
66. Saito M, Korsmeyer SJ & Schlesinger PH (2000) BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat Cell Biol 2, 553–555.
67. Martinez-Caballero S, Dejean LM, Kinnally MS, Oh KJ, Mannella CA & Kinnally KW (2009) Assembly of the mitochondrial apoptosis-induced channel, MAC. J Biol Chem 284, 12235–12245.
68. Antonsson B, Montessuit S, Sanchez B & Martinou JC (2001) BAX is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 276, 11615–11623.
69. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR & Newmeyer DD (2002) BID, BAX, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331–342.
70. Qian S, Wang W, Yang L & Hyang HW (2008) Structure of transmembrane pore induced by BAX-derived peptide: evidence for lipidic pores. Proc Natl Acad Sci USA 105, 17379–17383.
71. Schafer B, Quispe J, Choudhary V, Chipuk JE, Ajero TG, Du H, Schneiter R & Kuwana T (2009) Mitochondrial outer membrane proteins assist BID in BAX-mediated lipidic pore formation. Mol Biol Cell 20, 2276–2285.
72. Chipuk JE, McStay GP, Bharti A, Kuwana T, Clarke CJ, Siskind LJ, Obeid LM & Green DR (2012) Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148, 988–1000.
73. Renault TT, Floros KV, Elkholi R, Corrigan KA, Kushnareva Y, Wieder SY, Lindtner C, Serasinghe MN, Asciolla JJ, Buettner C et al. (2015) Mitochondrial shape governs BAX-induced membrane permeabilization and apoptosis. Mol Cell 57, 69–82.
74. Montessuit S, Somasekharan SP, Terrones O, Lucken-Ardjomande S, Herzig S, Schwarzenbacher R, Manstein DJ, Bossy-Wetzel E, Basanez G, Meda P et al. (2010) Membrane remodeling induced by the dynamin-related protein Drp1 stimulates BAX oligomerization. Cell 142, 889–901.
75. Garcia-Ruiz C, Mari M, Collel A, Morales A, Caballero F, Montero J, Terrones O, Basanez G & Fernandez-Checa JC (2009) Mitochondrial cholesterol in health and disease. Histol Histolpathol 24, 117–132.
76. Christenson E, Merlin S, Saito M & Schlesinger P (2008) Cholesterol effects on BAX pore activation. J Mol Biol 381, 1168–1183.
77. Lucken-Ardjomande S, Montessuit S & Martinou JC (2008) BAX activation and stress-induced apoptosis delayed by the accumulation of cholesterol in mitochondrial membranes. Cell Death Differ 15, 484–493.
78. Montero J, Montserrat M, Collel A, Morales A, Basanez G, Garcia-Ruiz C & Fernandez-Checa JC (2010) Cholesterol and peroxidized cardiolipin in mitochondrial membrane properties, permeabilization and cell death. Biochim Biophys Acta 1797, 1217–1224.
79. De Kroon AI, Dolis D, Mayer A, Lill R & de Kruijff B (1997) Phospholipid composition of highly purified mitochondrial outer membranes of rat liver and Neurosporacrassa: is cardiolipin present in the mitochondrial outer membrane? Biochim Biophys Acta 1325, 108–116.
80. Gonzalvez F, Pariselli F, Dupaigne P, Budihardjo I, Lutter M, Antonsson B, Diolez P, Manon S, Martinou JC, Goubern M et al. (2005) tBID interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates BAX and BAK. Cell Death Differ 12, 614–626.
81. Lucken-Ardjomande S, Montessuit S & Martinou JC (2008) Contributions to BAX insertion and oligomerization of lipids of the mitochondrial outer membrane. Cell Death Differ 15, 929–937.
82. Garcia-Saez AJ, Ries J, Orzaez M, Perez-Paya E & Schwille P (2009) Membrane promotes tBID interaction with BCL-XL. Nat Struct Mol Biol 16, 1178–1185.
83. Lutter M, Fang M, Luo X, Nishjima M, Xie X & Wang X (2000) Cardiolipin provides specificity for targeting of tBID to mitochondria. Nat Cell Biol 2, 754–761.
84. Lutter M, Perkins GA & Wang X (2001) The pro-apoptotic BCL-2 family member tBid localizes to mitochondrial contact sites. BMC Cell Biol 2, 22.
85. Gonzalvez F, Schug ZT, Houtkooper RH, MacKenzie ED, Brooks DG, Wanders RJA, Petit PX, Vaz FM & Gottlieb E (2008) Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol 183, 681–696.
86. Landeta O, Landajuela A, Gil D, Taneva S, Di Primo C, Sot B, Valle M, Frolov VA & Basanez G (2011) Reconstitution of proapoptotic BAK function in liposomes reveals a dual role for mitochondrial lipids in the BAK-drive membrane permeabilization process. J Biol Chem 286, 8123–8230.
87. Obeid LM, Linardic CM, Karolak LA & Hannun YA (1993) Programmed cell death induced by ceramide. Science 259, 1769–1771.
88. Siskind LJ, Feinstein L, Yu T, David JS, Jones D, Choi J, Zuckerman JE, Tan W, Hill RB, Hardwick JM et al. (2008) Anti-apoptotic BCL-2 family proteins disassemble ceramide channels. J Biol Chem 283, 6622–6630.
89. Perera MN, Lin SH, Peterson YK, Bielawska A, Szulc ZM, Bittman R & Colombini M (2012) BAX and BCL-XL exert their regulation on different sites of the ceramide channel. Biochem J 445, 81–91.
90. Ganesan V, Perera MN, Colombini D, Datsakovskiy D, Chadka K & Colombini M (2010) Ceramide and activated BAX act synergistically to permeabilize the mitochondrial outer membrane. Apoptosis 15, 553–562.
91. Beverly LJ, Howell LA, Hernandez-Corbacho M, Casson K, Chipuk JE & Siskind LJ (2013) BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins. Biochem J 452, 111–119.
92. Herman MD, Nyman T, Welin M, Lehtiö L, Flodin S, Trésaugues L, Kotenyova T, Flores A & Nordlund P (2008) Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim. FEBS Lett 582, 3590–3594.
93. Petros AM, Medek A, Nettesheim DG, Kim DH, Yoon HS, Swift K, Matayoshi ED, Olterdorf T & Fesik SW (2001) Solution structure of the antiapoptotic protein bcl-2. Proc Natl Acad Sci USA 98, 3012–3017.
94. Rautureau GJ, Day CL & Hinds MG (2010) The structure of Boo/Diva reveals a divergent Bcl–2 protein. Proteins 78, 2181–2186.
95. Ku B, Liang C, Jung JU & Oh BH (2011) Evidence that inhibition of BAX activation by BCL–2 involves its tight and preferential interaction with the BH3 domain of BAX. Cell Res 21, 627–641.
96. Rautureau GJ, Yabal M, Yang H, Huang DC, Kvansakul M & Hinds MG (2012) The restricted binding repertoire of Bcl–B leaves Bim as the universal BH3-only prosurvival Bcl–2 protein antagonist. Cell Death Dis 3, e443.
97. Denisov AY, Madiraju MS, Chen G, Khadir A, Beauparlant P, Attardo G, Shore GC & Gehring K (2003) Solution structure of human BCL–w: modulation of ligand binding by the C–terminal helix. J Biol Chem 287, 21124–21128.
98. Hinds MG, Lackmann M, Skea GL, Harrison PJ, Huang DC & Day CL (2003) The structure of Bcl–w reveals a role for the C–terminal residues in modulating biological activity. EMBO J 22, 1497–1507.
99. Denisov AY, Chen G, Sprules T, Moldoveanu T, Beauparlant P & Gehring K (2006) Structural model of the BCL–w–BID peptide complex and its interactions with phospholipid micelles. Biochemistry 45, 2250–2256.
100. Lee EF, Dewson G, Smith BJ, Evangelista M, Pettikiriarachchi A, Dogovski C, Perugini MA, Colman PM & Fairlie WD (2011) Crystal structure of a BCL–W domain-swapped dimer: implications for the functions of BCL–2 family proteins. Structure 19, 1467–1476.
101. Aritomi M, Kunishima N, Inohora N, Ishibashi Y, Ohta S & Morikawa K (1997) Crystal structure of rat Bcl–xL. Implications for the function of the Bcl–2 protein family. J Biol Chem 272, 27886–27892.
102. Petros AM, Nettesheim DG, Wang Y, Olejniczak ET, Meadows RP, Mack J, Swift K, Matayoshi ED, Zhang H, Thompson CB et al. (2000) Rationale for Bcl–xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci 9, 2528–2534.
103. Liu X, Dai S, Zhu Y, Marrack P & Kappler JW (2003) The structure of a Bcl–xL/Bim fragment complex: implications for Bim function. Immunity 19, 341–352.
104. O'Neill JW, Manion MK, Maguire B & Hockenberry DM (2006) BCL–XL dimerization by three-dimensional domain swapping. J Mol Biol 356, 367–381.
105. Oberstein A, Jeffrey PD & Shi Y (2007) Crystal structure of the Bcl-XL–Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 282, 13123–13132.
106. Feng W, Huang S, Wu H & Zhang M (2007) Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1. J Mol Biol 372, 223–235.
107. Lee EF, Sadowsky JD, Smith BJ, Czabotar PE, Peterson-Kaufman KJ, Colman PM, Gellman SH & Fairlie WD (2009) High-resolution structural characterization of a helical α/β-peptide foldamer bound to the anti-apoptotic protein Bcl-xL. Angew Chem Int Ed Engl 48, 4318–4322.
108. Czabotar PE, Lee EF, Thompson GV, Wardak AZ, Fairlie WD & Colman PM (2011) Mutation to Bax beyond the BH3 domain disrupts interactions with pro-survival proteins and promotes apoptosis. J Biol Chem 286, 7123–7131.
109. Ambrosi E, Capaldi S, Bovi M, Saccomani G, Perduca M & Monaco HL (2011) Structural changes in the BH3 domain of SOUL protein upon interaction with the anti-apoptotic protein Bcl-xL. Biochem J 438, 291–301.
110. Okamoto T, Zobel K, Fedorova A, Quan C, Yang H, Fairbrother WJ, Huang DC, Smith BJ, Deshayes K & Czabotar PE (2013) Stabilizing the pro-apoptotic BimBH3 helix (BimSAHB) does not necessarily enhance affinity or biological activity. ACS Chem Biol 8, 297–302.
111. Rajan S, Choi M, Baek K & Yoon HS (2015) Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis. Proteins 83, 1262–1272.
112. Rajan S, Choi M, Nguyen QT, Ye H, Liu W, Toh HT, Kang C, Kamariah N, Li C, Huang H et al. (2015) Structural transitions in Bcl-xL and its potential association with mitochondrial calcium ion transport. Sci Rep 5, 10609.
113. Czabotar PE, Lee EF, van Delft MF, Day CL, Smith BJ, Huang DC, Fairlie WD, Hinds MG & Colman PM (2007) Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci USA 104, 6217–6222.
114. Day CL, Smits C, Fan FC, Lee EF, Fairlie WD & Hinds MG (2008) Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1. J Mol Biol 380, 958–971.
115. Liu Q, Moldoveanu T, Sprules T, Matta-Camacho E, Mansur-Azzam N & Gehring K (2010) Apoptotic regulation by MCL-1 through heterodimerization. J Biol Chem 285, 19615–19624.
116. Fire E, Gullá SV, Grant RA & Keating AE (2010) Mcl-1–Bim complexes accommodate surprising point mutations via minor structural changes. Protein Sci 19, 507–519.
117. Stewart ML, Fire E, Keating AE & Walensky LD (2010) The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer. Nat Chem Biol 6, 595–601.
118. Smith BJ, Lee EF, Checco JW, Evangelista M, Gellman SH & Fairlie WD (2013) Structure-guided rational design of α/β-peptide foldamers with high affinity for BCL-2 family prosurvival proteins. ChemBioChem 14, 1564–1572.
119. Liu G, Poppe L, Aoki K, Yamane H, Lewis J & Szyperski T (2014) High-quality NMR structure of human anti-apoptotic protein domain Mcl-1(171–327) for cancer drug design. PLoS One 9, e96521.
120. Wang H, Takemato C, Akasaka R, Uchikubo-Kamo T, Kishishita S, Murayama K, Tereda T, Chen L, Liu ZJ, Wang BC et al. (2009) Novel dimerization mode of the human Bcl-2 family protein Bak, a mitochondrial apoptosis regulator. J Struct Biol 166, 32–37.